US 11,672,862 B2
Oral products with reduced irritation
Anthony Richard Gerardi, Winston-Salem, NC (US); Dwayne William Beeson, Kernersville, NC (US); Darrell Eugene Holton, Jr., Clemmons, NC (US); Ronald K. Hutchens, East Bend, NC (US); Christopher Keller, Advance, NC (US); Thomas H. Poole, Winston-Salem, NC (US); Andries Don Sebastian, Winston-Salem, NC (US); and Frank Kelley St. Charles, Bowling Green, NC (US)
Assigned to Nicoventures Trading Limited, London (GB)
Filed by NICOVENTURES TRADING LIMITED, London (GB)
Filed on Dec. 9, 2019, as Appl. No. 16/707,583.
Prior Publication US 2021/0170028 A1, Jun. 10, 2021
Int. Cl. A61K 47/10 (2017.01); A61K 9/00 (2006.01); A61K 31/455 (2006.01); A61K 31/52 (2006.01); A61K 47/38 (2006.01)
CPC A61K 47/10 (2013.01) [A61K 9/0056 (2013.01); A61K 31/455 (2013.01); A61K 31/52 (2013.01); A61K 47/38 (2013.01)] 18 Claims
 
1. An oral composition comprising:
an active ingredient that is releasable from the oral composition;
a filler; and
an irritation reducing agent effective to reduce irritation arising from the release of the active ingredient from the oral composition,
wherein the active ingredient comprises nicotine or caffeine,
wherein the active ingredient, the filler component, and the irritation reducing agent are combined as a mixture that is enclosed in a pouch to form a pouched product, the mixture being in a free-flowing particulate form,
wherein the irritation reducing agent is present in an amount effective to reduce the irritation in one or both of a consumer's mouth and throat,
and wherein the filler component is a cellulose material or cellulose derivative selected from the group consisting of methyl cellulose, hydroxypropyl cellulose (HPC), hydroxypropylmethyl cellulose (HPMC), hydroxyethyl cellulose, and carboxymethylcellulose (CMC) and is present in an amount of 20% to 75% by weight based on a total weight of the mixture.